Latamoxef Disodium

拉氧头孢二钠

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameLatamoxef Disodium
Drug Alias NameMoxalactam disodium氧头孢烯拉氧头孢拉他头孢钠拉氢头孢拉氧头孢 +[9] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1981/12/07
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHainan Hailing Chemipharma Corporation Ltd
Inactive CompaniesEli Lilly And Company
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01DD06
Related LinksWikipediaDrugBankKEGG